Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis
Previous studies demonstrated that CD147 molecule, highly expressed on the surface of various malignant tumor cells, significantly correlated with the malignancy of these cancers; however, the role of HAb18G/CD147 in endothelial cells has yet to be established. In this study, we found that the expre...
Saved in:
| Published in | Cancer Letters Vol. 278; no. 1; pp. 113 - 121 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Ireland
Elsevier Ireland Ltd
08.06.2009
Elsevier BV Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0304-3835 1872-7980 1872-7980 |
| DOI | 10.1016/j.canlet.2009.01.004 |
Cover
| Summary: | Previous studies demonstrated that CD147 molecule, highly expressed on the surface of various malignant tumor cells, significantly correlated with the malignancy of these cancers; however, the role of HAb18G/CD147 in endothelial cells has yet to be established. In this study, we found that the expression of HAb18G/CD147 was significantly upregulated in activated HUVECs. The inhibition of HAb18G/CD147 expression by specific siRNA led to significantly decreased angiogenesis in vitro. Our data indicate that HAb18G/CD147 may regulate angiogenesis via several mechanisms including proliferation, survival, migration, MMPs secretion, and PI3K/Akt activation. Our findings for the first time suggest that upregulation of HAb18G/CD147 in activated HUVECs might play an important role in angiogenesis. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 0304-3835 1872-7980 1872-7980 |
| DOI: | 10.1016/j.canlet.2009.01.004 |